EN
HI
Summary
As of 14 Sep, 2026, Ind-Swift Laboratories stock price is ₹385.35. During the trading session, the stock has moved between an intraday low of ₹372.30 and an intraday high of ₹391.40. Over the last 52 weeks, Ind-Swift Laboratories has traded between ₹87.15 and ₹404.00.
The stock has recorded a trading volume of 5,65,658 shares,. Its Average Traded Price (ATP) is ₹385.31, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 99 @ ₹385.35.
Ind-Swift Laboratories has an upper circuit limit of ₹462.40 and a lower circuit limit of ₹308.30. The total value traded stands at ₹21.80 CR, and the delivery percentage for the day is 31.79%.
The stock is currently traded with a market lot size of 1. Ind-Swift Laboratories also offers a dividend yield of 0%.
Ind-Swift Laboratories Share Price Chart
Ind-Swift Laboratories Share Key Metrics
Volume
5.66 L
Market Cap
3346.25 CR
LTQ@LTP
99@385.35
ATP
385.31
Var Margin
100 %
Circuit Range
308.3-462.4
Delivery %
31.79 %
Value
21.80 CR
ASM/GSM
No
Market Lot
1
Ind-Swift Laboratories Fundamentals
P/E Ratio
58.57
P/B Ratio
2.24
Div. Yield
0
Sector P/E
41.67
Sector P/B
3.6
Sec. Div. Yield
0.51
Ind-Swift Laboratories Resistance and Support
Pivot 383.02
Resistance
First Resistance
393.74
Second Resistance
402.12
Third Resistance
412.84
Support
First Support
374.64
Second Support
363.92
Third Support
355.54
Ind-Swift Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 375 | 385.35 | 2.08% | 391.39 | 372.29 |
| Thu Sep 10 2026 | 387.45 | 377.5 | -2.84% | 387.45 | 375.25 |
| Wed Sep 09 2026 | 389.7 | 388.54 | 0.06% | 404 | 381.35 |
Ind-Swift Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-07-10 | To consider issue of Warrants |
| 2026-05-28 | Audited Results |
| 2026-01-31 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-13 | Quarterly Results |
| 2025-02-12 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Ind-Swift Laboratories News
Ind-Swift Laboratories Ltd - 532305 - Outcome Of Preferential Issue Committee Meeting Held On Friday, 4Th September, 2026, As Per Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Ind Swift Laboratories' Preferential Issue Committee has set the issue price for preferential allotment of warrants at Rs. 196 each. This decision incorporates a revised valuation report and complies with SEBI ICDR Regulations.
Sep 04 2026 15:01:37
Ind-Swift Laboratories Ltd - 532305 - Audio Recording Of Earning Conference Call Held On 17.08.2026.
Ind Swift Laboratories announced the availability of its Q1 FY27 earnings conference call audio recording, held on August 17, 2026. This allows investors to access the discussion on financial results. The transcript will also be made available soon.
Aug 17 2026 19:05:28
Ind-Swift Laboratories Management
| Name | Position |
|---|---|
| Pardeep Verma | VP-Corp. Affairs, Company Secretary & Compliance Officer |
| Navrattan Munjal | Chairman & Managing Director |
Ind-Swift Laboratories Similar Stocks
Aarti Drugs Ltd.
428.50
0.00 (0.00%)
Unichem Laboratories Ltd.
539.70
0.00 (0.00%)
Kwality Pharmaceuticals Ltd.
3643.30
0.00 (0.00%)
Indraprastha Medical Corporation Ltd.
355.00
0.00 (0.00%)
Solara Active Pharma Sciences Ltd.
749.15
0.00 (0.00%)
Advanced Enzyme Technologies Ltd.
293.40
0.00 (0.00%)
Hikal Ltd.
224.95
0.00 (0.00%)
Dishman Carbogen Amcis Ltd.
167.25
0.00 (0.00%)
Sakar Healthcare Ltd.
1158.55
0.00 (0.00%)
Dr Agarwals Eye Hospital Ltd.
5306.50
0.00 (0.00%)
Ind-Swift Laboratories FAQs
The Buying Price of Ind-Swift Laboratories share is 385.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Ind-Swift Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ind-Swift Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Ind-Swift Laboratories shares is 58.57. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Ind-Swift Laboratories shares is 2.24. Useful to assess the stock's value relative to its book value.
To assess Ind-Swift Laboratories’s valuation compare Sector P/E, P/B which are 41.67 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Ind-Swift Laboratories is 3346.25 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Ind-Swift Laboratories share price is 404.00 & 87.15. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Ind-Swift Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in INDSWFTLAB
Or Download Choice FinX App
Invest in INDSWFTLAB
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade